Market Cap

La Jolla Pharmaceutical Company Market Capitalization:

$155.1 Million

USD as of Aug. 1, 2022

business La Jolla Pharmaceutical Company Company Profile

La Jolla Pharmaceutical Company Main Stock Listing

NASDAQ: LJPC

Market Capitalization History of La Jolla Pharmaceutical Company

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of La Jolla Pharmaceutical Company market cap

Date Market Cap YoY Change
Jan. 1, 2022 $115.5 M -24.35%
Jan. 1, 2021 $152.6 M -10.66%
Jan. 1, 2020 $170.8 M 13.41%
Jan. 1, 2019 $150.6 M -82.37%
Jan. 1, 2018 $854.3 M 76.14%
Jan. 1, 2017 $485.0 M 9.82%
Jan. 1, 2016 $441.6 M -18.91%
Jan. 1, 2015 $544.6 M 158.46%
Jan. 1, 2014 $210.7 M 69.00%
Jan. 1, 2013 $124.7 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

La Jolla Pharmaceutical Company Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

La Jolla Pharmaceutical Company has the following listings and related stock indices.


Stock: NASDAQ: LJPC

Stock: FSX: LJPP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.